Plaque-Stabilizing Action of Pitavastatin in Coronary Artery Disease - Plaque-Stabilizing Action of Pitavastatin in Coronary Artery Disease (PLATINA)

Hokkaido social insurance hospital0 个研究点目标入组 50 人开始时间: 2008年11月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1)Patients already receiving HMG-CoA reductase inhibitors (statin). (2)Patients who have received statins less than one year before. (3)Patients in whom the culprit lesion is in the left main trunk (4)Patients having triple-vessel disease and need PCI for all the three main branches. (5)Patients who had previous PCI on the lesion under evaluation. (6)Patients who have plaque in a non-culprit site on the PCI vessel and might require PCI for it during the treatment period. (7)Patients with cardiogenic shock (8)Patients with refractory ventricular tachyarrhythmia or fibrillation necessitating intravenous drug treatment or a defibrillator. (9)Patients with acute impulse-conducting disorder necessitating temporary insertion of a pacemaker. (10)Patients receiving cyclosporine. (11)Patients with allergy to pitavastatin or any other component of LIVALO. (12)Patients who are judged to be ineligible by the investigator.

发起方

Hokkaido social insurance hospital